Live from the NIH registry
Studies recruiting near Lubbock right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Peripheral Arterial Disease, Atherosclerosis of Extremities
Phase 3
Interventional 6,150 participants sought
Texas Tech University Health Sciences — Lubbock, Texas (2.1 mi)
· Sponsor: Population Health Research Institute
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Lubbock, Texas (2.1 mi)
· Sponsor: Ambros Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lubbock, Texas (2.1 mi)
· Sponsor: Hoffmann-La Roche
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Heat and Exercise in Aging as Therapy (HEAT)
Prediabetic State
N/A
Interventional 54 participants sought
Texas Tech University — Lubbock, Texas (2.1 mi)
· Sponsor: Texas Tech University
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center — Lubbock, Texas (2.1 mi)
· Sponsor: Pfizer
Annatto-derived GG for Statin-associated Myopathy
Myopathy; Primary
Phase 1, Phase 2
Interventional 95 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi)
· Sponsor: Texas Tech University Health Sciences Center
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
GI Alliance - Lubbock ( Site 5012) — Lubbock, Texas (2.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 231 participants sought
Site Number - 1048 — Lubbock, Texas (2.1 mi)
· Sponsor: Immunovant Sciences GmbH
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Radiation Retinopathy, Visual Impairment
Phase 3
Interventional 600 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi)
· Sponsor: Jaeb Center for Health Research
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Lubbock, Texas (2.1 mi)
· Sponsor: TG Therapeutics, Inc.
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi)
· Sponsor: Children's Oncology Group
Telehealth to Improve Quality of Life in Persons Living in Rural Texas
Mental Health Issue, Quality of Life
N/A
Interventional 60 participants sought
Garrison Institute on Aging — Lubbock, Texas (2.1 mi)
· Sponsor: Texas Tech University
Snacks and Brain Health
Cognitive Assessment, Psychological Function
Phase 1, Phase 2
Interventional 60 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi)
· Sponsor: Texas Tech University Health Sciences Center
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi)
· Sponsor: Mercy Health Ohio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Phase 3
Interventional 980 participants sought
Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092 — Lubbock, Texas (2.1 mi)
· Sponsor: Sanofi
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi)
· Sponsor: Children's Oncology Group
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Non-squamous Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Lubbock, Texas (2.1 mi)
· Sponsor: AstraZeneca
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Lubbock, Texas (2.1 mi)
· Sponsor: MoonLake Immunotherapeutics AG
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Relapsed/Refractory Multiple Myeloma (RRMM)
Phase 4
Interventional 30 participants sought
Texas Tech University Health Science Center School of Medicine — Lubbock, Texas (2.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging
Stroke, Intracranial Atherosclerotic Stenosis (ICAS)
N/A
Observational 300 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi)
· Sponsor: Yale University